Clinical Trial Detail


Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at :

NCT ID NCT04655976
Title Study of Cobolimab in Combination With Dostarlimab and Docetaxel in Advanced NSCLC Participants (COSTAR Lung)
Recruitment Recruiting
Gender both
Phase Phase II
Variant Requirements Yes
Sponsors GlaxoSmithKline

lung non-small cell carcinoma



Cobolimab + Docetaxel + Dostarlimab-gxly

Docetaxel + Dostarlimab-gxly

Age Groups: adult | senior
Covered Countries USA | ITA | FRA | ESP | DEU | CAN

Additional content available in CKB BOOST